326030 Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Sk Biopharmaceutica stock prices and determine the direction of Sk Biopharmaceuticals Co's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Sk Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
326030
On December 20, 2024 Sk Biopharmaceuticals Co had Relative Strength Index of 50.73.
On December 21 2024 Sk Biopharmaceuticals Co was traded for 102,100 at the closing time. The highest price during the trading period was 103,600 and the lowest recorded bid was listed for 99,700 . There was no trading activity during the period 0.0. Lack of trading volume on December 21, 2024 did not result in any price rise and fall. The trading price change to the current price is 0.98% .
For every potential investor in 326030, whether a beginner or expert, Sk Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. 326030 Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in 326030. Basic forecasting techniques help filter out the noise by identifying Sk Biopharmaceutica's price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sk Biopharmaceutica stock to make a market-neutral strategy. Peer analysis of Sk Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Sk Biopharmaceutica by comparing valuation metrics with similar companies.
Sk Biopharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sk Biopharmaceutica's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sk Biopharmaceutica's current price.
Market strength indicators help investors to evaluate how Sk Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sk Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Sk Biopharmaceutica stock market strength indicators, traders can identify Sk Biopharmaceuticals Co entry and exit signals to maximize returns.
The analysis of Sk Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sk Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting 326030 stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Sk Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sk Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Sk Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sk Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sk Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sk Biopharmaceuticals Co to buy it.
The correlation of Sk Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sk Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sk Biopharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sk Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Sk Biopharmaceutica financial ratios help investors to determine whether 326030 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 326030 with respect to the benefits of owning Sk Biopharmaceutica security.